Arterium
Olena Pyshna is an experienced professional in the pharmaceutical and healthcare industries, currently serving as Chief Growth Officer at YURiA-PHARM LLC since December 2019. Prior to this role, Olena held multiple positions at Arterium, including Director of the Consumer Health division and Business Development Manager, since July 2012. Olena's earlier experience includes roles at Фармак from September 2006 to July 2012, where responsibilities included Product Group Manager, Product Manager, and Medical Representative. Olena began a career in the pharmaceutical field as a Pharmacist at Гамма-55 from May 2005 to May 2006. Education includes a PMD in Marketing from МИМ Киев (2011-2012) and a degree from the National University of Pharmacy (2001-2006), in addition to attending Kyiv-Mohyla Business School in 2013.
This person is not in any teams
This person is not in any offices
Arterium
1 followers
The Arterium Corporation operates in the industry which takes care of the most important values – human health and life. Every day nearly two thousand of our employees make their individual contribution to the achievement of this humane goal. We strive to ensure that every patient who uses our medicines, every doctor who is determined to overcome disease, every business partner – feels our care, responsibility, and confidence we put into high quality and effectiveness of our products. That is why the Arterium Corporation has a corporate philosophy and attitude of cooperation towards patients, doctors and business partners which is firmly based on the concept “Closer to people”. We are certain that in order to create and develop high quality and effective medications it is necessary to possess the requisite knowledge, technology, and business acumen as well as to cultivate among our employees a selfless and heartfelt attitude towards their work allied with a deep understanding of the significance of our corporate mission and values. That is why guided by our “Closer to people” idea, the Arterium Corporation is one of the leading pharmaceutical companies in Ukraine and is steadily expanding its presence on CIS markets.